Vanguard Capital Management’s BioCardia BCDA Stock Holding History
Bought
Maintained
Sold
Other funds holding BCDA
CM
PP
Vanguard Capital Management's BCDA Position: Q3 2026 in Review
Vanguard Capital Management held its BioCardia (BCDA) position steady in Q3 2026 at 124,591 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #3828.
Vanguard Capital Management first reported a position in BCDA in Q1 2026 and has held it in 3 quarters since. The position peaked at $154K in Q2 2026. 18 funds tracked by Wall St. Rank hold BCDA as of Q3 2026.
- Vanguard Capital Management held 124,591 shares of BioCardia worth $126K as of Q3 2026.
- Vanguard Capital Management left its BioCardia share count unchanged in Q3 2026.
- BioCardia made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3828 holding.
- Vanguard Capital Management first reported a position in BioCardia in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's BioCardia position peaked at $154K in Q2 2026.
- 18 funds tracked by Wall St. Rank held BioCardia as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.